Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-052922
Filing Date
2025-04-10
Accepted
2025-04-10 17:06:27
Documents
3
Period of Report
2025-05-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A apvo-2025-pre14a_-_proxy.htm PRE 14A 427272
2 GRAPHIC img115451103_0.jpg GRAPHIC 188488
3 GRAPHIC img115451103_1.jpg GRAPHIC 141333
  Complete submission text file 0000950170-25-052922.txt   882752
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37746 | Film No.: 25829150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)